Depending on the pharmacy, Semglee injector pens cost about $150 to $190 without insurance for a typical month's supply, compared to $340 to $520 for the same supply of Lantus.

Levemir and Lantus are both long-acting injectable insulins that can be used for long-term management of diabetes. Insulin is a hormone that is naturally produced in the body by the pancreas. It ...

About SoloSTAR SoloSTAR is an easy-to-use disposable pen for administration of Lantus and Apidra. SoloSTAR allows to administer doses from 1 up to 80 units, in one unit increments, in one injection.

Lantus ® (“Lantus”) is Sanofi’s insulin glargine product. The U.S. Food and Drug Administration (FDA) first approved Lantus in 2000 as a sterile solution of insulin glargine for use as an ...

The Lantus ClikSTAR pen, designed in partnership with nearly 2,000 patients and 500 nurses, is the result of over four years of intensive development and testing aimed at addressing patients' needs.

INDIANAPOLIS — A diabetes drug made by Eli Lilly and Amylin Pharmaceuticals has received approval from the Food and Drug Administration for use with an insulin product made by Sanofi. Lilly and ...

Sanofi’s Lantus, its most commonly prescribed insulin, will sell for $35 a month through GoodRx Holdings Inc. in a deal that signals the drug-discount site’s growing business with large pharma ...

Four studies involving Sanofi SA's Lantus insulin appeared to blunt concerns that it might cause cancer. Lantus is the top-selling insulin in the U.S. One major study looked at the use of Lantus ...

Sanofi said it will cut the price of Lantus by 78% and short-acting Apidra by 70% as of Jan. 1, 2024. The prices these companies set for insulin have increasingly been scrutinized by analysts, ...